FDA Approves First IUD For 8 Years of Pregnancy Prevention
Drug Topics
NOVEMBER 15, 2022
The approval extends the use of Liletta for an additional 2 years.
Tue.Nov 15, 2022
387 
A ‘bold vision’ to prevent diabetes
PharmaVoice
NOVEMBER 15, 2022
Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
COVID-19 Vaccine Efficacy in Adolescents Shown Through Real-World Data
Drug Topics
NOVEMBER 15, 2022
A real-world study determined the efficacy of mRNA vaccines for protection against COVID-19 in adolescents.
#HLTH: ‘Unicorns are real’ — and here’s how they can navigate a challenging biotech market
PharmaVoice
NOVEMBER 15, 2022
Venture capitalists tackle ways companies can stay afloat while the market’s turbulent waters rise.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BLA Submitted for Lebrikizumab Atopic Dermatitis Treatment
Drug Topics
NOVEMBER 15, 2022
BLA submission is based on phase 3 trial results evaluating the safety and efficacy of lebrikizumab.
Intervention Groups May Help Lower HIV Risk Among Gay, Bisexual Youth
Pharmacy Times
NOVEMBER 15, 2022
Approximately 80% of all HIV infections among teens are from the gay and bisexual population.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
‘A very worrying scenario’: Internal documents on India Covid-19 vaccine raise troubling questions about approval process
STAT
NOVEMBER 15, 2022
As the Covid-19 pandemic spread across the world two years ago, one of India’s leading biotech companies was racing to develop a vaccine with crucial backing from the Indian government. The shot engineered by Bharat Biotech was, in part, an important effort to create a home-grown product that could bolster the fortunes of the Indian pharmaceutical industry.
Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss
Fierce Healthcare
NOVEMBER 15, 2022
Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss. hlandi. Tue, 11/15/2022 - 09:18.
Wellness is the Future of Pharmacy But is the Profession Prepared?
Pharmacy Times
NOVEMBER 15, 2022
Currently, no national pharmacy organization has defined wellness in the pharmacy profession, which is needed so that others have a sense of guidance around wellness within the profession.
Data privacy concerns don’t hinder digital health app usage
pharmaphorum
NOVEMBER 15, 2022
A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users. With the HLTH 2022 event now well underway, digital health industry leaders all gathered together to attend in Las Vegas this week, the juli survey results reveal consumer responses to be more varied than one would have expected when it comes to data privacy.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Dapagliflozin Found Clinically, Cost Effective Treating Chronic Kidney Disease
Pharmacy Times
NOVEMBER 15, 2022
Dapagliflozin and standard of care found to slow the decline in kidney function and lower the incidence of kidney failure.
HLTH22: Google, Epic ink deal to migrate hospital EHRs to the cloud to ramp up use of AI, analytics
Fierce Healthcare
NOVEMBER 15, 2022
HLTH22: Google, Epic ink deal to migrate hospital EHRs to the cloud to ramp up use of AI, analytics. hlandi. Wed, 11/16/2022 - 02:42.
Mindfulness-Based Stress Reduction Found Effective Treating Anxiety Disorders
Pharmacy Times
NOVEMBER 15, 2022
Anxiety disorders include generalized anxiety, social anxiety, panic disorder, and fear of certain places or situations, including crowds and public transportation.
STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease
STAT
NOVEMBER 15, 2022
BOSTON — The executives behind Altos Labs would really, really like people to stop saying they’re trying to reverse aging. They have a couple things going against them on this count. For one, the first article about the biotech and its $3 billion stash talked about Silicon Valley billionaires “ living forever.” And then there’s their most prominent scientist’s tendency to talk openly about people living to 130.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Three Strategies for Pharmacists to Maximize Their Potential as Caregivers Beyond the Bench
Pharmacy Times
NOVEMBER 15, 2022
In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
HLTH 2022 – Day 2
pharmaphorum
NOVEMBER 15, 2022
Early on Day 2, Matthew Holt (who we recently featured in our Health Innovators video series ) will interview Walmart EVP Dr. Cheryl Pegus & SCAN Health Plan’s Dr. Sachin Jain. Then we’ll hear from Aptar Digital Health’s Sai Shankar and Pierre Laurent in a session all about patients as partners in healthcare. The day will continue with other hot topics for pharma, including health equity, cell and gene therapy, oncology, and pharmacy model disruption.
FDA Grants Accelerated Approval to Mirvetuximab Soravtansine-gynx for Platinum-Resistant Ovarian Cancer Treatment
Pharmacy Times
NOVEMBER 15, 2022
Mirvetuximab soravtansine-gynx (Elahere; ImmunoGen Inc) approved FR?-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
STAT+: Amazon jumps into direct-to-consumer telehealth, launching a rival to Ro and Hims
STAT
NOVEMBER 15, 2022
True to its e-commerce expertise, Amazon is jumping into the world of direct-to-consumer telehealth. On Tuesday, the tech goliath launched a virtual health storefront that individuals can access through the main Amazon website and its mobile app, offering the ability to message teleproviders and obtain prescriptions for about 20 health conditions. Amazon has been making significant shifts in its health care strategy in the last few months: In July, it announced plans to acquire primary care comp
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Midwest nonprofits Sanford Health, Fairview Health Services target a 58-hospital merger for 2023
Fierce Healthcare
NOVEMBER 15, 2022
Midwest nonprofits Sanford Health, Fairview Health Services target a 58-hospital merger for 2023. dmuoio. Tue, 11/15/2022 - 13:05.
Opinion: Replace the failure of Medicare Advantage with ‘Medicare Part F’
STAT
NOVEMBER 15, 2022
Medicare Advantage began life as a brilliant idea: a public-private partnership to keep older people healthier and reduce costs. At the time in 1992, both President George H.W. Bush and his challenger, Bill Clinton, supported it. An editorial in The New York Times declared, “The debate over health care reform is over. Managed competition has won.
Machine Learning and Data Analysis for Optimal Productivity of Pharmaceutical Water Systems
BioPharm
NOVEMBER 15, 2022
Leveraging smart technology and SMEs for significant operational and financial benefits.
Roche deepens ties with Jnana with a second licensing deal
pharmaphorum
NOVEMBER 15, 2022
Swiss pharma group Roche has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap into the Boston-based biotech drug discovery platform for a wide-ranging push across cancer, immune-mediated, and neurological diseases. The new agreement – announced on the same day that Jnana finalised a $107 million series C financing – has a potential deal value of around $2 billion and comes two years after Roche paid $40 million upfront with $1 billion at the back-end for a
Advise Patients on Cold, Cough, Flu Medications and When to Seek Medical Care
Pharmacy Times
NOVEMBER 15, 2022
A plethora of products complicates self-care, but pharmacists can provide guidance on nonprescription options.
Senate Dems press CMS for more consumer protections in Medicare Advantage
Fierce Healthcare
NOVEMBER 15, 2022
Senate Dems press CMS for more consumer protections in Medicare Advantage. rking. Tue, 11/15/2022 - 16:52.
Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu
STAT
NOVEMBER 15, 2022
BOSTON — In science journalism, there’s a well-worn technique reporters reach for when they’re interviewing a researcher and the technical material starts whizzing over their heads. “OK, explain it again, and this time, as if you were talking to your mother.” The conjured image of a parent tends to do just the trick; prompting an illuminating alchemy of clarity infused with excitement.
Target's Q3 earnings miss the mark
Drug Store News
NOVEMBER 15, 2022
Target reported Q3 GAAP earnings per share of $1.54, down 49.3% from $3.04 in 2021 and adjusted EPS of $1.54, a decrease of 49.1% compared with $3.03 in 2021.
The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard
STAT
NOVEMBER 15, 2022
WHITE OAK, Md. — The Food and Drug Administration, as the name suggests, is supposed to police the United States’ food and drug supply. But there are still illegal products available for easy purchase at gas stations and convenience stores all over the country — including in the FDA’s own backyard. We know, we bought them.
What’s the best heartburn medicine for you?
The Checkup by Singlecare
NOVEMBER 15, 2022
If you’re one of the 60 million Americans that experience heartburn and indigestion every month, you may find yourself searching for relief and wondering what the best heartburn medicine is. With so many options on the market, it can be hard to know where to start. Whether you’re looking for an over-the-counter heartburn medicine or something a little stronger, it’s important that you find something that works for you because heartburn can be a sign of gastroesophageal reflux.
STAT+: More drugmakers are expanding access in poorer countries, but progress continues to lag overall
STAT
NOVEMBER 15, 2022
For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps to widen access to their medicines in low and middle-income countries, but the poorest countries continue to be disproportionately overlooked, according to a new analysis. All 20 of the drugmakers reviewed now have an access-to-medicine strategy, up from 17 previously, and all but one company has integrated access-to-medicine strategies into their overall corporate strategies.
2022 WHO Biosimilar Guideline improves access, IGBA says
European Pharmaceutical Review
NOVEMBER 15, 2022
The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. According to IGBA, the World Health Organization ( WHO) Biosimilars Guideline has been a useful tool for health authorities to boost international regulatory convergence and consistency of term
STAT+: Spain’s antitrust regulator fines drugmaker for ‘excessive’ pricing of a rare disease drug
STAT
NOVEMBER 15, 2022
Antitrust regulators in Spain have fined a drugmaker $10.6 million for years of “excessive” price hikes on a rare disease medicine, the latest instance in which European authorities have cracked down on the pharmaceutical industry for harming consumers and taxpayers. At issue is a medicine called CDCA that is used to treat people with a rare genetic metabolic disease known as cerebrotendinous xanthomatosis, or CTX.
Lilly said to be pulling Twitter ads after verification debacle
pharmaphorum
NOVEMBER 15, 2022
Eli Lilly is reported to be axing millions of dollars worth of advertising spend on Twitter, in the wake of a fake post by an account claiming to be the drugmaker’s ‘verified’ account last week, that wreaked havoc with its share price. It seems Lilly might have cut Twitter some slack if it had responded promptly to its frantic attempts to get the post – put up by someone who paid $8 to verify the imposter @EliLillyandCo account – which claimed that “insulin is free now.&#
STAT+: Hospital systems Sanford, Fairview plan to create $14 billion Midwest powerhouse
STAT
NOVEMBER 15, 2022
Two not-for-profit Midwest hospital systems are seeking to merge, creating what would be a health care powerhouse with nearly $14 billion in annual revenue. Sanford Health, a 47-hospital system based in Sioux Falls, S.D., and Fairview Health Services, an 11-hospital academic health system based in Minneapolis, said Tuesday they’re giving their union a second shot after an initial bid failed about a decade ago.
Let's personalize your content